Stock listing
Lucid Diagnostics Inc.
Selected listing: LUCD · NASDAQ · USD · US
Lucid Diagnostics Inc. (NASDAQ:LUCD), Health Technology. Latest release Sep 22, 2026: Lucid Diagnostics Advances Multiple EsoGuard® and EsoCheck® Payment…
- Ticker
- NASDAQ:LUCD
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- NASDAQ
- Currency
- USD
About Lucid Diagnostics Inc.
Lucid Diagnostics Inc. is a public company traded under the ticker LUCD in the American market. Lucid Diagnostics focuses on developing innovative diagnostic solutions.
Latest news from Lucid Diagnostics Inc.
Lucid Diagnostics Advances Multiple EsoGuard® and EsoCheck® Payment, Billing and Coding Pathways
September 22, 2026
Lucid Diagnostics Provides Business Update and Reports Second Quarter 2026 Financial Results
August 13, 2026
Lucid Diagnostics Secures Commercial Coverage Policy Spanning Multiple Health Plans for its EsoGuard® Esophageal DNA Test
August 5, 2026
Lucid Diagnostics to Hold Second Quarter 2026 Business Update Conference Call and Webcast on August 13, 2026
July 30, 2026
Lucid Diagnostics Provides Business Update and Reports First Quarter 2026 Financial Results
May 13, 2026
Events
Research Lucid Diagnostics Inc.
Lucid Diagnostics Inc. company profile
View the public company page for Lucid Diagnostics Inc. on 6ix.
Lucid Diagnostics Inc. news
Read company news and market updates connected to Lucid Diagnostics Inc..
Lucid Diagnostics Inc. investor events
Find investor webinars, events, and replay context for Lucid Diagnostics Inc..